Post job

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) overview

Industry
Hospital & Health Care
Revenue
Headquarters
Employees
31
Founded in
Website
Organization type
Private
Social media
Establishments of health practitioners engaged in the practice of health fields, not elsewhere classified. Practitioners may or may not be licensed or certified, depending on the State in which they practice. Establishments operating as clinics of health practitioners, not elsewhere classified, are included in this industry.
Founded in 1995, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is an established company that loves to hire graduates from Johnson & Wales University, with 17.9% of its employees having attended Johnson & Wales University. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has established itself as a great place to work in New Jersey, and it is number 5 on Zippia's list of Best Companies to Work for in Lawrenceville, NJ.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a small health care company based in New Jersey with only 31 employees and an annual revenue of $16.6M.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s mission statement

To promote health economics and outcomes research excellence to improve decision making for health globally.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employee reviews

Be the first to review!

Do you work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

Help job seekers learn about working at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

On this page

Be the first to review International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

The team at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

  • The key people at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is Harry J. Smolen.
Key people
Harry J. Smolen

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) rankings

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is ranked #81 on the Best Health Care companies to work for in New Jersey list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Evaluate International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s commitment to diversity and inclusion.

Zippia waving zebra

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) diversity

9.3
Diversity score
We calculated International Society for Pharmacoeconomics and Outcomes Research (ISPOR)’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)’s workforce.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) diversity summary. Zippia estimates International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s workforce.
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has 31 employees.
  • 57% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are women, while 43% are men.
  • The most common ethnicity at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is White (63%).
  • 13% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are Black or African American.
  • 11% of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) employees are Hispanic or Latino.
  • The average employee at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) makes $45,946 per year.
  • Employees at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) stay with the company for 6.7 years on average.

Do you work at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

Were you satisfied with International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s salary and benefits?

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) financial performance

8.8
Performance score

Are you an executive, HR leader, or brand manager at International Society for Pharmacoeconomics and Outcomes Research (ISPOR)?

Claiming and updating your company profile on Zippia is free and easy.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) FAQs

Search for jobs

Zippia gives an in-depth look into the details of International Society for Pharmacoeconomics and Outcomes Research (ISPOR), including salaries, political affiliations, employee data, and more, in order to inform job seekers about International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The employee data is based on information from people who have self-reported their past or current employments at International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data presented on this page does not represent the view of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and its employees or that of Zippia.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) may also be known as or be related to INTERNATIONAL SOCIETY FOR, International Society For Pharmacoeconomics And Outcomes Research ..., International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Joshua Friedman.